Average Co-Inventor Count = 4.62
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cygnus, Inc. (10 from 75 patents)
2. Respivant Sciences Gmbh (10 from 10 patents)
3. Patara Pharma, LLC (4 from 4 patents)
4. Alexza Pharmaceuticals, Inc. (3 from 114 patents)
5. Respira Therapeutics, Inc. (3 from 14 patents)
6. Savara Inc. (3 from 5 patents)
7. Animas Technologies, LLC (2 from 15 patents)
8. Respivant Services Gmbh (1 from 1 patent)
36 patents:
1. 12364701 - PDE5 inhibitor powder formulations and methods relating thereto
2. 11911390 - PDE5 inhibitor powder formulations and methods relating thereto
3. 11806314 - PDE5 inhibitor powder formulations and methods relating thereto
4. 10835512 - Methods of treating respiratory syncytial virus infections
5. 10596146 - Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
6. 10583113 - Cromolyn compositions for treatment of pulmonary fibrosis
7. 10561635 - Cromolyn compositions for treatment of pulmonary fibrosis
8. 10561608 - Dry powder Vancomycin compositions and associated methods
9. 10463613 - Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
10. 10420722 - Dry powder vancomycin compositions and associated methods
11. 10398673 - Mast cell stabilizers treatment for systemic disorders
12. 10391078 - Methods for the treatment of mast cell related disorders with mast cell stabilizers
13. 10265267 - Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
14. 10265296 - Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
15. 10238628 - Mast cell stabilizers treatment for systemic disorders